FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2029651427> ?p ?o ?g. }

• W2029651427 endingPage "35" @default.
• W2029651427 startingPage "23" @default.
• W2029651427 abstract "Recent studies have demonstrated a loss of cannabinoid CB1 receptors in the postmortem basal ganglia of patients affected by Huntington's disease (HD) and in transgenic mouse models for this disease. These studies have led to the notion that substances that increase the endocannabinoid activity, such as receptor agonists or inhibitors of endocannabinoid uptake and/or metabolism, might be useful in the treatment of hyperkinetic symptoms of this disease. In the present study, we employed a rat model of HD generated by bilateral intrastriatal injections of 3-nitropropionic acid (3-NP), a toxin that selectively damages striatal GABAergic efferent neurons. These rats exhibited biphasic motor disturbances, with an early (1–2 weeks) hyperactivity followed by a late (3–4 weeks) motor depression. Analysis of GABA, dopamine, and their related enzymes, glutamic acid decarboxylase and tyrosine hydroxylase, in the basal ganglia proved marked decreases compatible with the motor hyperkinesia. In addition, mRNA levels for CB1 receptor, neuronal-specific enolase, proenkephalin, and substance P decreased in the caudate-putamen of 3-NP-injected rats. There were also reductions in CB1 receptor binding in the caudate putamen, the globus pallidus, and, to a lesser extent, the substantia nigra. By contrast, mRNA levels for tyrosine hydroxylase in the substantia nigra remained unaffected. Interestingly, the administration of AM404, an inhibitor of endocannabinoid uptake, to 3-NP-injected rats attenuated motor disturbances observed in the early phase of hyperactivity. Administration of AM404 also tended to induce recovery from the neurochemical deficits caused by the toxin in GABA and dopamine indices in the basal ganglia. In summary, morphological, behavioral, and biochemical changes observed in rats intrastriatally lesioned with 3-NP acid were compatible with a profound degeneration of striatal efferent GABAergic neurons, similar to that occurring in the brain of HD patients. As expected, a loss of CB1 receptors was evident in the basal ganglia of these rats. However, the administration of substances that increase endocannabinoid activity, by inhibiting the uptake process, allowed an activation of the remaining population of CB1 receptors, resulting in a significant improvement of motor disturbances and neurochemical deficits. These observations might be relevant to the treatment of hyperkinetic symptoms in HD, a human disorder with unsatisfactory symptomatic treatment for most patients. Synapse 44:23–35, 2002. © 2002 Wiley-Liss, Inc." @default.
• W2029651427 created "2016-06-24" @default.
• W2029651427 creator A5001683046 @default.
• W2029651427 creator A5020787270 @default.
• W2029651427 creator A5036189795 @default.
• W2029651427 creator A5049686253 @default.
• W2029651427 creator A5054775332 @default.
• W2029651427 creator A5067242440 @default.
• W2029651427 creator A5069868485 @default.
• W2029651427 creator A5081538305 @default.
• W2029651427 date "2002-01-30" @default.
• W2029651427 modified "2023-10-01" @default.
• W2029651427 title "Alleviation of motor hyperactivity and neurochemical deficits by endocannabinoid uptake inhibition in a rat model of Huntington's disease" @default.
• W2029651427 cites W1563847798 @default.
• W2029651427 cites W1836729582 @default.
• W2029651427 cites W1967558194 @default.
• W2029651427 cites W1971766335 @default.
• W2029651427 cites W1973295005 @default.
• W2029651427 cites W1973331021 @default.
• W2029651427 cites W1978211805 @default.
• W2029651427 cites W1981876620 @default.
• W2029651427 cites W1983729920 @default.
• W2029651427 cites W1992286667 @default.
• W2029651427 cites W1992854762 @default.
• W2029651427 cites W1993068285 @default.
• W2029651427 cites W1994188899 @default.
• W2029651427 cites W1997485399 @default.
• W2029651427 cites W1999771095 @default.
• W2029651427 cites W2001331393 @default.
• W2029651427 cites W2001413877 @default.
• W2029651427 cites W2002062235 @default.
• W2029651427 cites W2003253817 @default.
• W2029651427 cites W2004485518 @default.
• W2029651427 cites W2006114741 @default.
• W2029651427 cites W2007439129 @default.
• W2029651427 cites W2015663165 @default.
• W2029651427 cites W2021950684 @default.
• W2029651427 cites W2022819833 @default.
• W2029651427 cites W2028420970 @default.
• W2029651427 cites W2029126939 @default.
• W2029651427 cites W2029153838 @default.
• W2029651427 cites W2029468394 @default.
• W2029651427 cites W2035145629 @default.
• W2029651427 cites W2038443115 @default.
• W2029651427 cites W2040051923 @default.
• W2029651427 cites W2041366408 @default.
• W2029651427 cites W2042196312 @default.
• W2029651427 cites W2044632947 @default.
• W2029651427 cites W2046945092 @default.
• W2029651427 cites W2052643496 @default.
• W2029651427 cites W2052988246 @default.
• W2029651427 cites W2054394983 @default.
• W2029651427 cites W2058354156 @default.
• W2029651427 cites W2060694966 @default.
• W2029651427 cites W2063550046 @default.
• W2029651427 cites W2064128689 @default.
• W2029651427 cites W2072780035 @default.
• W2029651427 cites W2073197774 @default.
• W2029651427 cites W2075312140 @default.
• W2029651427 cites W2077091868 @default.
• W2029651427 cites W2078747214 @default.
• W2029651427 cites W2079879584 @default.
• W2029651427 cites W2081335794 @default.
• W2029651427 cites W2088607604 @default.
• W2029651427 cites W2088777175 @default.
• W2029651427 cites W2099570835 @default.
• W2029651427 cites W2117593813 @default.
• W2029651427 cites W2122189667 @default.
• W2029651427 cites W2133559511 @default.
• W2029651427 cites W2140075873 @default.
• W2029651427 cites W2168882723 @default.
• W2029651427 cites W2171422018 @default.
• W2029651427 cites W2171637070 @default.
• W2029651427 cites W2218524127 @default.
• W2029651427 cites W4247729308 @default.
• W2029651427 cites W4250119652 @default.
• W2029651427 cites W4376848266 @default.
• W2029651427 doi "https://doi.org/10.1002/syn.10054" @default.
• W2029651427 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11842443" @default.
• W2029651427 hasPublicationYear "2002" @default.
• W2029651427 type Work @default.
• W2029651427 sameAs 2029651427 @default.
• W2029651427 citedByCount "114" @default.
• W2029651427 countsByYear W20296514272012 @default.
• W2029651427 countsByYear W20296514272013 @default.
• W2029651427 countsByYear W20296514272014 @default.
• W2029651427 countsByYear W20296514272015 @default.
• W2029651427 countsByYear W20296514272016 @default.
• W2029651427 countsByYear W20296514272017 @default.
• W2029651427 countsByYear W20296514272018 @default.
• W2029651427 countsByYear W20296514272019 @default.
• W2029651427 countsByYear W20296514272020 @default.
• W2029651427 countsByYear W20296514272021 @default.
• W2029651427 countsByYear W20296514272022 @default.
• W2029651427 crossrefType "journal-article" @default.
• W2029651427 hasAuthorship W2029651427A5001683046 @default.
• W2029651427 hasAuthorship W2029651427A5020787270 @default.
• W2029651427 hasAuthorship W2029651427A5036189795 @default.

• next